These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21913897)

  • 1. Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase.
    Moroni F; Cozzi A; Chiarugi A; Formentini L; Camaioni E; Pellegrini-Giampietro DE; Chen Y; Liang S; Zaleska MM; Gonzales C; Wood A; Pellicciari R
    Br J Pharmacol; 2012 Mar; 165(5):1487-500. PubMed ID: 21913897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment.
    Ding Y; Zhou Y; Lai Q; Li J; Gordon V; Diaz FG
    Brain Res; 2001 Oct; 915(2):210-7. PubMed ID: 11595210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
    Singh N; Sharma G; Singh N; Hanif K
    Int J Stroke; 2014 Jul; 9(5):560-8. PubMed ID: 23013350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor, ameliorates ischemic brain damage in a non-human primate model.
    Matsuura S; Egi Y; Yuki S; Horikawa T; Satoh H; Akira T
    Brain Res; 2011 Sep; 1410():122-31. PubMed ID: 21741620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Treatment with Poly(ADP-Ribose) Polymerase-1 Inhibitor (JPI-289) Reduces Infarct Volume and Improves Long-Term Behavior in an Animal Model of Ischemic Stroke.
    Kim Y; Kim YS; Kim HY; Noh MY; Kim JY; Lee YJ; Kim J; Park J; Kim SH
    Mol Neurobiol; 2018 Sep; 55(9):7153-7163. PubMed ID: 29383691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia.
    Egi Y; Matsuura S; Maruyama T; Fujio M; Yuki S; Akira T
    Brain Res; 2011 May; 1389():169-76. PubMed ID: 21420942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of combination of poly (ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal ischemia in rats.
    Gupta S; Kaul CL; Sharma SS
    Neurol Res; 2004 Jan; 26(1):103-7. PubMed ID: 14977067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ADP-ribose) polymerase inhibition with HYDAMTIQ reduces allergen-induced asthma-like reaction, bronchial hyper-reactivity and airway remodelling.
    Lucarini L; Pini A; Gerace E; Pellicciari R; Masini E; Moroni F
    J Cell Mol Med; 2014 Mar; 18(3):468-79. PubMed ID: 24444146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ADP-ribose) polymerase inhibition protect neurons and the white matter and regulates the translocation of apoptosis-inducing factor in stroke.
    Komjáti K; Mabley JG; Virág L; Southan GJ; Salzman AL; Szabó C
    Int J Mol Med; 2004 Mar; 13(3):373-82. PubMed ID: 14767566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats.
    Nakajima H; Kakui N; Ohkuma K; Ishikawa M; Hasegawa T
    J Pharmacol Exp Ther; 2005 Feb; 312(2):472-81. PubMed ID: 15466246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
    Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
    Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in the response to poly(ADP-ribose) polymerase-1 deletion and caspase inhibition after stroke.
    Liu F; Lang J; Li J; Benashski SE; Siegel M; Xu Y; McCullough LD
    Stroke; 2011 Apr; 42(4):1090-6. PubMed ID: 21311064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of KCL-440, a new poly(ADP-ribose) polymerase inhibitor, in the rat middle cerebral artery occlusion model.
    Ikeda Y; Hokamura K; Kawai T; Ishiyama J; Ishikawa K; Anraku T; Uno T; Umemura K
    Brain Res; 2005 Oct; 1060(1-2):73-80. PubMed ID: 16202986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection by the PARP inhibitor PJ34 modulates cerebral and circulating RAGE levels in rats exposed to focal brain ischemia.
    Greco R; Tassorelli C; Mangione AS; Levandis G; Certo M; Nappi G; Bagetta G; Blandini F; Amantea D
    Eur J Pharmacol; 2014 Dec; 744():91-7. PubMed ID: 25446913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rd blocks AIF mitochondrio-nuclear translocation and NF-κB nuclear accumulation by inhibiting poly(ADP-ribose) polymerase-1 after focal cerebral ischemia in rats.
    Hu G; Wu Z; Yang F; Zhao H; Liu X; Deng Y; Shi M; Zhao G
    Neurol Sci; 2013 Dec; 34(12):2101-6. PubMed ID: 23463404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance.
    Gerace E; Scartabelli T; Formentini L; Landucci E; Moroni F; Chiarugi A; Pellegrini-Giampietro DE
    Eur J Neurosci; 2012 Jul; 36(1):1993-2005. PubMed ID: 22639866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin gallate alleviates neuronal cell damage against focal cerebral ischemia in rats.
    Park DJ; Kang JB; Koh PO
    J Vet Med Sci; 2020 May; 82(5):639-645. PubMed ID: 32224555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDP-choline reduces pro-caspase and cleaved caspase-3 expression, nuclear DNA fragmentation, and specific PARP-cleaved products of caspase activation following middle cerebral artery occlusion in the rat.
    Krupinski J; Ferrer I; Barrachina M; Secades JJ; Mercadal J; Lozano R
    Neuropharmacology; 2002 May; 42(6):846-54. PubMed ID: 12015211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals.
    Koh SH; Park Y; Song CW; Kim JG; Kim K; Kim J; Kim MH; Lee SR; Kim DW; Yu HJ; Chang DI; Hwang SJ; Kim SH
    Eur J Neurosci; 2004 Sep; 20(6):1461-72. PubMed ID: 15355313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.